Vitiligo is an autoimmune condition that affects around 70 million people worldwide, causing areas of skin to lose their pigment. The condition is caused by genetics and potentially an event, such as a sunburn, emotional trigger, or chemical exposure. Vitiligo appears when melanocytes, the cells responsible for making pigment, are destroyed, and the skin is deprived of its color.
Vitiligo treatments often involve topical medications with active ingredients like tacrolimus.
SKNV’s customized medication contains this active ingredient, eliminating potentially harmful inactive ingredients for certain patients as determined by a healthcare provider. SKNV’s Nuju Cream contains 0.1% tacrolimus, providing a clinically different solution to vitiligo, for each patient as determined by a prescriber.
Ask your provider about SKNV. They can determine which SKNV formulation is best for your skin and prescribe your Rx directly from their office. You can leave with the medication in hand, or have your Rx shipped directly to your home.